Medical Weight Loss & GLP-1 Management
Personalized care. Ongoing support. Convenient telehealth.
Initial Weight Loss Consultation
$200
Virtual comprehensive medical weight loss evaluation with a board certified provider.
Review of medical history, goals, and treatment options
Assessment for GLP-1 medication eligibility
Personalized recommendations based on clinical needs
*If you are clinically eligible for and enroll in the Medical Weight Loss Program within 7 days of your consultation, you will recive a 40% discount off your first month.
First Month GLP-1 Weight Loss Management Program
$500
GLP-1 medication delivered to your home (1 month of medications and supplies)
Customized meal plan provided within 72 hours of consultation
Customized workout plan provided within 72 hours of consultation
One check-in via secure messaging from a licensed healthcare professional
*$40% off discount will be applied for 1st month ONLY when booked within 7 days of initial weight loss consultation.
*Virtual consultation is required for all patients prior to receiving any weight loss medications.
Ongoing Weight Loss Follow up & Medication Management
$500/month
One virtual follow-up visit with a board certified provider to assess treatment response, discuss ongoing goals, and to adjust medication when clinically appropriate
GLP-1 medication delivered to your home (1 month of medications and supplies)
Continued nutrition, fitness, weight managment and treatment monitoring
Additional Follow-Up Visits
$40 per visit
For additional follow-up appointments beyond those included in the monthly program
Flexible Payment Options
Self Pay (Debit or Credit Card)
Afterpay*
Klarna*
*Subject to eligibility, applicable plan requirements, and third party payment-provider approval. Shining Hearts Medical Group does not determine eligibility, approve, or deny financing or payment plans, or control terms, conditions, or decisions of third party payment providers. All approvals and payment arrangements are managed soley by the applicable provider.
Enrollment and prescribing are subject to clinical evaluation and appropriateness.